Willow
Willow is a telehealth company that helps people lose excess weight through prescription weight loss medications. They provide instant access to GLP-1 medications for qualified patients, with state-licensed doctors creating a personalized program based on individual goals and health conditions. According to Willow, patients using GLP-1 medications through their program can lose up to 20% of their body weight. So far, the company has supported more than 5,000 patients. Willow offers injectable compounded semaglutide (Semaglutide Plus) and tirzepatide (Tirzepatide Plus). These are the generic forms of the main ingredients found in well-known but often costly weight loss drugs such as Ozempic, Wegovy, and Zepbound. Compounded medications may also contain other ingredients, such as vitamins, tailored to the patient’s needs. In addition, Willow also has oral semaglutide in the form of tablets, eliminating the need to use needles. All programs are subscription-based, with monthly charges and weekly dosages dispatched to your home in discreet packaging.